RAPP Kronos AI forecast
A 30-trading-day price forecast for Rapport Therapeutics Inc. (RAPP) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Rapport Therapeutics Inc. at $39.41 on 2026-12-08, +43.1% from the last close of $27.54 on 2026-10-27. Eight out of ten sampled paths end between $37.44 and $43.83, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of RAPP
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $27.67 | $27.03 | $29.99 |
| 2026-11-10 | $31.00 | $30.02 | $35.07 |
| 2026-11-17 | $35.03 | $33.21 | $38.74 |
| 2026-11-24 | $38.29 | $36.69 | $38.90 |
| 2026-12-01 | $39.27 | $37.76 | $40.85 |
| 2026-12-08 | $39.41 | $37.44 | $43.83 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for RAPP?
- Kronos AI's median forecast for RAPP is $39.41 in 30 trading days, +43.1% from the last close, with a 10–90% range of $37.44 to $43.83.
- Is the RAPP Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC